KrijtheBPKunstABenjaminEJ, et al.Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J2013; 34: 2746–2751.
2.
ConenDChaeCUGlynnRJ, et al.Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA2011; 305: 2080–2087.
3.
ConenDRodondiNMullerA, et al.Relationships of overt and silent brain lesions with cognitive function in patients with atrial fibrillation. J Am Coll Cardiol2019; 73: 989–999.
4.
WolfPAAbbottRDKannelWB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke1991; 22: 983–988.
5.
RogerVL. Epidemiology of heart failure. Circulation Research2013; 113: 646–659.
6.
ShahKSXuHMatsouakaRA, et al.Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J Am Coll Cardiol2017; 70: 2476–2486.
7.
ChenJDharmarajanKWangY, et al.National trends in heart failure hospital stay rates, 2001 to 2009. J Am Coll Cardiol2013; 61: 1078–1088.
8.
WangTJLarsonMGLevyD, et al.Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation2003; 107: 2920–2925.
9.
LingLHKistlerPMKalmanJM, et al.Comorbidity of atrial fibrillation and heart failure. Nat Rev Cardiol2016; 13: 131–147.
BenjaminEJLevyDVaziriSM, et al.Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA1994; 271: 840–844.
12.
HeJOgdenLGBazzanoLA, et al.Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med2001; 161: 996–1002.
13.
ChatterjeeNAChaeCUKimE, et al.Modifiable risk factors for incident heart failure in atrial fibrillation. JACC Heart Fail2017; 5: 552–560.
14.
GuoYLipGYApostolakisS. Inflammation in atrial fibrillation. J Am Coll Cardiol2012; 60: 2263–2270.
15.
ConenDRidkerPMEverettBM, et al.A multimarker approach to assess the influence of inflammation on the incidence of atrial fibrillation in women. Eur Heart J2010; 31: 1730–1736.
16.
VasanRSSullivanLMRoubenoffR, et al.Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation2003; 107: 1486–1491.
17.
MannDL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res2002; 91: 988–998.
18.
NymoSHHultheJUelandT, et al.Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA. Eur J Heart Fail2014; 16: 68–75.
19.
MitrofanovaLBOrshanskayaVHoSY, et al.Histological evidence of inflammatory reaction associated with fibrosis in the atrial and ventricular walls in a case-control study of patients with history of atrial fibrillation. Europace2016; 18: iv156–iv62.
20.
BattyGDJungKJMokY, et al.Oral health and later coronary heart disease: cohort study of one million people. Eur J Prev Cardiol2018; 25: 598–605.
21.
Chang Y, Woo HG, Park J, et al. Improved oral hygiene care is associated with decreased risk of occurrence for atrial fibrillation and heart failure: A nationwide population-based cohort study. Eur J Prev Cardiol. 2020; 27: 1835–1845.
22.
TrohelGBertaud-GounotVSolerM, et al.Socio-economic determinants of the need for dental care in adults. PLoS One2016; 11: e0158842–e0158842.
23.
TsakosGDemakakosPBreezeE, et al.Social gradients in oral health in older adults: findings from the English longitudinal survey of aging. Am J Public Health2011; 101: 1892–1899.
24.
MouLNorbyFLChenLY, et al.Lifetime risk of atrial fibrillation by race and socioeconomic status: ARIC study (atherosclerosis risk in communities). Circ Arrhythm Electrophysiol2018; 11: e006350–e006350.
25.
PotterELHopperISenJ, et al.Impact of socioeconomic status on incident heart failure and left ventricular dysfunction: systematic review and meta- analysis. Eur Heart J Qual Care Clin Outcomes2019; 5: 169–179.
